Arvinas

About Arvinas

Arvinas is a clinical-stage biotechnology company creating a new class of drugs based on targeted protein degradation . Arvinas’ Mission is to improve the lives of patients with serious diseases by pioneering therapies created with its revolutionary PROTAC® protein degradation platform. Since its founding in 2013, Arvinas’ new and advanced PROTAC® Discovery Engine platform has helped the company emerge as a leader in the discovery and development of targeted protein degraders.

PROTAC® Discovery Engine

Leading the Way

At Arvinas, we are passionate and driven by amazing science, believing that success at work requires a sense of purpose. Arvinas’ values have driven us since our founding, but those principles aren’t just words; they guide our most important decisions. Arvinas believes that every problem has a solution and challenge the perceived limits of drug discovery through targeted protein degradation - an approach to drug development that could dramatically change patients' lives.

Working With Purpose

PROTAC® Technology Partnerships

Arvinas believes in the expansive power of our PROTAC® protein degradation technology through strategic partnerships. Our global collaboration with Pfizer aims to develop and commercialize our investigational oral PROTAC® protein degrader, vepdegestrant, for the potential treatment of those with ER+ breast cancer. Other strategic partners include Genentech, and Arvinas is exploring the application of PROTAC® protein degradation to agriculture through Oerth Bio.

Partnerships

Company photos

No more previous content

No more next content

Employee perspectives

• Celebrating a Decade of Arvinas!

  Celebrating a Decade of Arvinas!

  By John Houston

  This July marks a monumental milestone in our company’s history as we celebrate Arvinas’ 10-year anniversary. It’s an incredibly proud moment, and it…

  Jul 12, 2023
• Arvinas 2022 Annual Report

  Arvinas 2022 Annual Report

  By John Houston

  We recently released the Arvinas 2022 Annual Report, which always includes a letter to our shareholders. In reflecting on the company’s progress in…

  Jun 14, 2023
• Alzheimer’s & Brain Awareness Month: Looking Ahead

  Alzheimer’s & Brain Awareness Month: Looking Ahead

  By John Houston

  June is Alzheimer’s and Brain Awareness Month, a national campaign that is close to our hearts at Arvinas given our focus on patients with…

  Jun 9, 2023

Employee testimonials

• Gaurav Arora

  “We’ve managed to hire very collaborative people who want to learn from each other and grow. There is a sense of a common goal in mind, and everyone wants to work toward it. Everyone wants to learn from each other and be collaborative, knowing that what we’re going to do is difficult, but it can become transformational for the industry. ​”